Category: Q3

Insulet Corp. records 57% jump in 2Q revenues

July 30, 2010 by MassDevice staff

Insulet Corp. (Nasdaq:PODD) is moving into its second decade as a business looking at new markets for its OmniPod insulin infusion device, improving sales, better terms on its long-term debt and a little extra cash.

But it's still fighting a problem that's as old as the company: Net losses typically running out to eight digits.

BD's profits shrink 10 percent on tax provision

July 29, 2010 by MassDevice staff

The tax man took a bite out of Becton, Dickinson and Company's (NYSE:BDX) bottom line during the third quarter.

The Franklin Lakes, N.J.-based medical device and diagnostic kit-maker reported $306.9 million in net income, or $1.29 per diluted share, on $1.88 billion in sales during the three months ended June 30, a 10 percent slide from the $341 million, or $1.39 per diluted share profit on sales of $1.82 billion during the same period last year.

Zoll posts 285 percent increase in profits during Q3

July 29, 2010 by MassDevice staff

Zoll Medical Corp. (NSDQ:ZOLL) continues to have a rebound year in 2010, posting a 285 percent increase in its bottom line during the three month period ended on July 4.

The Chelmsford, Mass-based resuscitation products maker reported revenues of $111.3 million in its third quarter, compared with $95 million during the same period last year, a 17 percent increase overall. The brisk sales helped the company post a $5.7 million profit, a 285 percent increase from the $1.5 million in net income the company posted for the same period last year.

Analogic's Q1 sales, earnings slide

December 10, 2009 by MassDevice staff

Analogic Corp. (NSDQ:ALOG) posted lower sales and earnings during the first quarter, but its medical technology business clawed its way toward last year's levels. Analogic also settled a dispute with an activist investor group and inked a new deal for its security business.

The Peabody, Mass.-based imaging equipment maker posted sales of $95.4 million for the three months ended Oct. 31, down 6.1 percent compared with $101.6 million during the same period last year. Net income plummeted 91.9 percent to $26 million, from $320 million during Q1 2009.

Cantel Medical's Q1 sales rise, earnings soar

December 9, 2009 by MassDevice staff

Cantel Medical Corp. (NYSE:CMN) posted first-quarter sales of $71 million for the three months ended Oct. 31, up 10.2 percent compared with $64.4 million during the same period last year. Net income rose 85 percent to $6.2 million, compared with $3.3 million during Q3 2008:

Press Release

Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase

Optos plunges into the red for fiscal 2009

December 2, 2009 by MassDevice staff

Sales for Optos plc (LSE:OPTS) slid 3.6 percent during fiscal 2009, to $97.2 million, but its strategy to boost pay-per-patient revenues continued to gain traction even as it posted a net loss for the year.

The British retinal imaging firm, which has operations in Marlborough, Mass., said its pay-per-patient revenues for the fiscal year ended Sept. 30 rose 2 percent to $93.5 million, compared with $91.7 million during the same period last year, as it developed its strategy to shift from large capital equipment sales.

Medtronic's Q2 sales, earnings rise

November 24, 2009 by MassDevice staff

Medtronic Inc. (NYSE:MDT) posted net earnings of $868 million on sales of $3.84 billion during the second quarter, compared with net earnings of $547 million in $3.57 billion in sales during the same period last year.

Outside the U.S., sales grew 12 percent to $1.54 billion, or 40 percent of total revenues.

The Minneapolis-based medical device monolith said its Q2 2010 results for the three months ended Oct. 30 were strong enough for it to upgrade its earnings guidance for the full year. Medtronic said it expects diluted earnings-per-share of between $3.17 and $3.22 for fiscal 2010, up from its previous forecast of $3.10 to $3.20.